Is Your Portfolio Ready for This Altcoins 2300 Explosion Make Sure Youve Added It
Analyst Sheldon recently delved into how sideways market movement could signal either a continuation or a reversal. He carefully examined the performance of various altcoins against Bitcoin, highlighting their strength and potential for outperformance. In his latest analysis video, the analyst confidently stated that several altcoins are poised to surge and steal the spotlight.
One of the tokens he focused on was Theta, reminiscing about its remarkable rally in the past. Theta experienced a jaw-dropping surge from approximately 90 cents to $3.5, showcasing an impressive 2300% gain. He predicted a similar trend unfolding, anticipating a robust upward movement from $2 to $5, with even higher targets set at $7.
Injective was another token that caught his attention, positioned strategically within short-term and medium-term buy zones. He cautioned about potential pullbacks in case Bitcoin experiences a 2-3% dip. However, once the trend is confirmed, he anticipated Injective mirroring the surge seen in Kaspa, potentially hitting the $40 mark in the short term and gearing up for a possible move to $70.
Cetus, a token known for its solid fundamentals, also made it onto his radar. He suggested considering adding more if the trend is confirmed on the daily chart, envisioning targets around 16 cents in the short term and 30 cents in the higher time frames, reflecting a potential 3x increase.
Highlighting tokens like BNB breaking their all-time highs, he pointed out the significant strength in the market. Utilizing Fibonacci analysis from the top to the bottom, he noted that BNB tested the 61a level and is now surpassing previous highs. He projected potential targets of $1,000 and $1,500 for BNB.
Moving on, he discussed Solana, hinting at a potential minor retest while underscoring the importance of catching breakouts. He set his sights on a range between $240 to $280 for SOL, advising to buy on pullbacks to around $170, with a suggested stop loss at $160.